Trading is not allowed on this stock
Trading has been suspended by the exchange due to high volatility and additional risk measures
Kabra Drugs Ltd Performance
- ₹10.06Day's Price Range₹10.06
52 Week's Low
₹5.1452-Week Price Range₹10.06
| Returns % | |
| 1 Month Return | + 4.9 % |
| 3 Month Return | + 10.07 % |
| 1 Year Return | + 86.64 % |
| Market Stats | |
| Previous Close | ₹9.59 |
| Open | ₹10.06 |
| Volume | 500.00 |
| Upper Circuit | - |
| Lower Circuit | - |
| Market Cap | ₹10.14Cr |
Kabra Drugs Ltd Key Statistics
| P/E Ratio | 0 |
| PEG Ratio | 0 |
| Market Cap | ₹10.14 Cr |
| P/B Ratio | -2.15 |
| EPS | 0 |
| Dividend Yield | 0 |
| Sector | Pharmaceuticals |
| ROE | 0 |
Kabra Drugs Ltd Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹10.14 Cr | 166.3% | 0.81 | NA | NA | |
| NA | ₹902.03 Cr | 212.57% | 0.62 | ₹28 Cr | ₹125 Cr | |
| NA | ₹15.50 Cr | 15.85% | 0.69 | NA | NA | |
| NA | ₹1,163.26 Cr | 14.59% | 0.68 | -₹25 Cr | ₹335 Cr | |
| NA | ₹415.00 Cr | 20.66% | 0.57 | NA | NA |
About Kabra Drugs Ltd
Kabra Drugs Ltd, has also registered itself as a supplier to the Ministry of Defence, and has designed a variety of new products for the global market. Having acquired experience in producing injectables, soft gelatin capsules, liquids oral and external, especially liquor-based products, the company is now looking to expand its customer base worldwide.
Share Price: ₹10.06 per share as on 16 Dec, 2024 04:01 PM
Market Capitalisation: ₹10.14Cr as of today
| Organisation | Kabra Drugs Ltd |
| Headquarters | |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
Insights on Kabra Drugs Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 1 year, Kabra Drugs stock has moved up by 86.6%
- POSITIVE IMPACT
Best in 1 Year
In the last 1 year, Kabra Drugs has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
NO EFFECTAgainst Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 137.2% return, outperforming this stock by 45.4%
- NO EFFECT
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 100.00% of holdings in Jun 2024 quarter
Kabra Drugs Ltd Financials
Kabra Drugs Ltd Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 0% | 0.00 | |
| Foreign Institutions | 0% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 100% | 0.00 | |
| Others | 0% | 0.00 |
FAQs on Kabra Drugs Ltd
- Get a PAN card.
- Open a Demat account.
- Open a Trading account.
- Link your Demat account to your Trading account.
- Fund your Trading account.
- Place an order to buy Kabra Drugs Ltd shares.
Kabra Drugs Ltd (524322) share price today is ₹10.06
Kabra Drugs Ltd is not listed on NSE
Kabra Drugs Ltd is listed on BSE
- Today’s highest price of Kabra Drugs Ltd is ₹10.06.
- Today’s lowest price of Kabra Drugs Ltd is ₹10.06.
Today’s traded volume of Kabra Drugs Ltd(524322) is 500.00.
Today’s market capitalisation of Kabra Drugs Ltd(524322) is ₹10.14Cr.
| Kabra Drugs Ltd(524322 | Price |
|---|---|
52 Week High | ₹10.06 |
52 Week Low | ₹5.14 |
Kabra Drugs Ltd(524322) share price is ₹10.06. It is down -0.00% from its 52 Week High price of ₹10.06
Kabra Drugs Ltd(524322) share price is ₹10.06. It is up 95.72% from its 52 Week Low price of ₹5.14
| Kabra Drugs Ltd(524322 | Returns |
|---|---|
1 Day Returns | 0.47% |
1 Month Returns | 4.9% |
3 Month Returns | 10.07% |
1 Year Returns | 86.64% |